<DOC>
	<DOCNO>NCT02663609</DOCNO>
	<brief_summary>Chart review study collect patient data medical chart patient treat Korlym® treatment ACTH independent adrenal Cushing 's Syndrome .</brief_summary>
	<brief_title>Retrospective Chart Review Study Korlym Treatment ACTH Independent Cushing 's Syndrome</brief_title>
	<detailed_description>A retrospective , multi-center , chart review study collect patient data medical chart patient treat Korlym® treatment ACTH independent adrenal Cushing 's Syndrome . Treatment Korlym® minimum 3 month duration follow-up minimum 3 month . Only sit identified patient appropriate protocol invite participate .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<criteria>Diagnosed ACTH independent endogenous Cushing 's Syndrome Available adrenal imaging prior treat Korlym® Treated Korlym® follow least 3 month ( followup data available ) Diagnosed adrenocortical carcinoma Participant clinical trial ( ) observational period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cushing 's Syndrome</keyword>
	<keyword>Mifepristone</keyword>
	<keyword>Adrenal</keyword>
	<keyword>Retrospective</keyword>
	<keyword>Chart Review</keyword>
</DOC>